Dietary Supplementation with Mono-Lactate Glyceride Enhances Intestinal Function of Weaned Piglets

SIMPLE SUMMARY: The aim of this study is to investigate the effects of mono-lactate glyceride on growth performance and the morphology and function of the intestine in weaned piglets, which provided a theoretical basis for its practical application as a new feed additive. Dietary supplementation with 0.6% mono-lactate glyceride (LG) essentially decreased diarrhea rate and the contents of malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) in the ileum and jejunum, increased the expression of intestinal tight junction protein (Occludin) and the activities of superoxide dismutase (SOD) and catalase (CAT) in the ileum and colon, and improved the intestinal morphologic structure. In addition, mono-lactate glyceride supplementation could enhance intestinal mucosal growth, promote intestinal mucosal water and nutrient transport and lipid metabolism, and enhance antiviral and immune function and antioxidant capacity. Overall, these results suggested that dietary supplementation with mono-lactate glyceride could decrease the diarrhea rate. ABSTRACT: Mono-lactate glyceride (LG) is a short-chain fatty acid ester. It has been shown that short-chain fatty acid esters play an important role in maintaining intestinal structure and function. The aim of this study is to investigate the effects of mono-lactate glyceride on growth performance and intestinal morphology and function in weaned piglets. Sixteen 21-day-old weaned piglets of similar weight were distributed arbitrarily to two treatments: The control group (basal diet) and the LG group (basal diet + 0.6% mono-lactate glyceride). The experiment lasted for 21 days. On day 21 of the trial, piglets were weighed, and blood and intestinal samples were collected for further analysis. Results showed that dietary supplementation with 0.6% mono-lactate glyceride decreased (p < 0.05) the diarrhea rate and the contents of malondialdehyde and hydrogen peroxide in the ileum and jejunum and increased (p < 0.05) the expression of intestinal tight junction protein (Occludin) and the activities of superoxide dismutase and catalase in the ileum and colon. In addition, mono-lactate glyceride supplementation could enhance intestinal mucosal growth by increasing (p < 0.05) the mRNA levels of extracellular regulated protein kinases, promote intestinal mucosal water and nutrient transport and lipid metabolism by increasing (p < 0.05) the mRNA levels of b(0,+) amino acid transporter, aquaporin 3, aquaporin 10, gap junction protein alpha 1, intestinal fatty acid-binding protein, and lipoprotein lipase, enhance antiviral and immune function by increasing (p < 0.05) the mRNA levels of nuclear factor kappa-B, interferon-β, mucovirus resistance protein II, 2’-5’-oligoadenylate synthetase-like, interferon-γ, C-C motif chemokine ligand 2, and toll-like receptor 4, and enhance antioxidant capacity by increasing (p < 0.05) the mRNA levels of NF-E2-related factor 2 and glutathione S-transferase omega 2 and decreasing (p < 0.05) the mRNA level of NADPH oxidase 2. These results suggested that dietary supplementation with mono-lactate glyceride could decrease the diarrhea rate by improving intestinal antioxidant capacity, intestinal mucosal barrier, intestinal immune defense function, and intestinal mucosal water and nutrient transport. Collectively, dietary supplementation with 0.6% mono-lactate glyceride improved the intestinal function of weaned piglets.